Recent Advances in Peptide Therapeutics

  • ID: 4327601
  • Report
  • 15 pages
  • Frost & Sullivan
1 of 3
This edition of the Genetic Technology TOE depicts trends across peptide therapeutics. The study covers a variety of disease indications in which peptide therapeutics are being used. A summary of interventional, industry-funded clinical studies using peptide therapeutics for leukemia is also presented.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Note: Product cover images may vary from those shown
2 of 3
Innovations in Peptide Therapeutics
  • Stapled Peptides for Advanced Cancer Management
  • Novel Therapeutic for Paroxysmal Nocturnal Hemoglobinuria
  • Glucagon Analog for Treating Hypoglycemia in Type 1 Diabetics
  • Synthetic Surfactant Technology for Management of Respiratory Distress Syndrome in Premature Infants
Clinical Trial Analysis and Industry Interactions
  • Clinical Trial Analysis
  • Industry Interactions
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown